The Fifth Circuit court’s ruling, which is being appealed, reinstates a requirement that patients visit a health care provider in person to obtain mifepristone, upending abortion access in the United States.
Source: https://www.nytimes.com/2026/05/02/us/abortion-pill-mifepristone-5th-circuit-court-ruling.html